Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial

Günter U. Höglinger, Irene Litvan, Nuno Mendonça, Deli Wang, Hui Zheng, Beatrice Rendenbach‐Mueller, Hoi‐Kei Lon, Ziyi Jin, Nahome Fisseha, Kumar Budur, Michael Gold, Davis C. Ryman, Hana Florian, Anwar Ahmed, Ikuko Aiba, Alberto Albanese, Kelly Bertram, Yvette Bordelon, James H. Bower, Jared R. Brosch, Daniel O. Claassen, Carlo Colosimo, Jean‐Christophe Corvol, Paola Cudia, Antonio Daniele, Luc Defebvre, Erika Driver‐Dunckley, Antoine Duquette, Roberto Eleopra, Alexandre Eusébio, Victor S.C. Fung, David Geldmacher, Lawrence I. Golbe, Francisco Grandas, Deborah J. Hall, Taku Hatano, Günter U. Höglinger, Lawrence S. Honig, Jennifer Hui, Diana Kerwin, Akio Kikuchi, Thomas Kimber, Takashi Kimura, Rajeev Kumar, Irene Litvan, Peter A. Ljubenkov, Stefan Lorenzl, Albert Ludolph, Zoltán Mari, Nikolaus R. McFarland, Wassilios G. Meissner, Pablo Mir Rivera, Hidek Mochizuki, John M. Morgan, Renato P. Munhoz, Noriko Nishikawa, John O`Sullivan, Tomoko Oeda, Hideki Oizumi, Osamu Onodera, Fabienne Ory‐Magne, Elizabeth Peckham, Ronald B. Postuma, Aldo Quattrone, Joseph Quinn, Stefano Ruggieri, Justyna R. Sarna, Paul E. Schulz, John Slevin, Michele Tagliati, Daryl Wile, Zbigniew K. Wszołek, Tao Xie, Theresa Zesiewicz